Why the study?
Does intracoronary thrombolysis using urokinase improve infarct size and cardiac function in patients with acute myocardial infarction?
Population
79 patients with acute myocardial infarction
Comparison
Intracoronary thrombolysis using urokinase… vs Patients not reperfused with ICT compared to…
Design
Cohort
Follow-up
mean 18.1±12.8 months
Authors
Loading...
Recanalization associated with smaller infarcts and higher LVEF in low-QRS anterior MI; leaves open urokinase benefit in prospective trials.
Does intracoronary thrombolysis using urokinase improve infarct size and cardiac function in patients with acute myocardial infarction?
Intracoronary thrombolysis with urokinase reduces infarct size and preserves cardiac function primarily in acute myocardial infarction patients with an initial QRS score less than 4.
Tokuyasu et al. (1986) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: